Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Muhammad Usman Shams
Precision medicine is an emerging field in medicine for disease prevention and treatment that takes into account biological characteristics of an individual patient to allow delivery of more individualized medical care. In the case of cancer, such biological characteristics are based largely on analysis of tumor tissue. With the advent of modern techniques like immunohistochemistry & gene sequencing and the enhanced understanding of the tumor immune microenvironment, the modern pathology labs are able to derive more and more biologically useful information from biospecimens. This information has not only allowed sub-classification of cancers for better therapeutic and prognostic knowledge, but also has provided unprecedented possibilities to study the biology of pre-malignancy. Journey of modern pathology towards precision medicine in cancer is expected to provide unique opportunities for the dissemination and implementation of public health interventions.